DNAnexus and Discovery Life Sciences have joined forces to streamline precision health data analysis, while also announcing a new CEO and major strategic expansions. With state-of-the-art facilities, advanced technologies, and global brand enhancements, Discovery Life Sciences is expanding its high-throughput proteomics services, offering real-time access to a massive inventory of ethically procured and comprehensively characterized biospecimens for faster preclinical, translational, and clinical research studies.
Accelerate your research with Discovery Life Sciences' extensive inventory of human blood, non-blood biofluids, and other biomarkers. Their wide range of human diseased blood specimens, collected from a global clinical site network, along with normal blood-derived products, allows for a deeper understanding of disease pathogenesis and the identification of novel therapeutic targets. Additionally, Discovery Life Sciences offers advanced technologies and solutions for genomics, molecular pathology, cell biology, and development and clinical trial services.
Generated from the website